Smoking is the single biggest cause of COPD. In high-income countries, tobacco use accounts for over 70% of all cases. But smoking isn’t the only path to the disease. Roughly 25 to 30% of people with COPD have never smoked, which means other exposures, genetics, and environmental factors play a real role too.
How Smoking Damages the Lungs
Cigarette smoke contains thousands of chemical compounds, including an enormous concentration of reactive molecules in the gas phase alone. When inhaled repeatedly over years, these chemicals set off a chain of destructive processes in lung tissue. The damage works on multiple fronts at once: chronic inflammation, destruction of the tiny air sacs where oxygen exchange happens, excess mucus production, and a breakdown of the structural proteins that keep airways open.
One of the core problems is an imbalance between enzymes that break down tissue and the proteins meant to protect it. Smoking tips this balance heavily toward destruction. Enzymes released by immune cells, particularly neutrophils that flood into the lungs in response to smoke, chew through the elastic fibers of the airways and air sacs. At the same time, smoke triggers cells lining the airways to overproduce mucus, narrowing the passages and making it harder to move air in and out.
In the deeper parts of the lung, smoke disrupts the normal maintenance and repair cycle of the air sacs. Cells that would ordinarily regenerate damaged tissue instead undergo programmed cell death at accelerated rates, and the blood vessels feeding the air sacs lose critical growth signals. The result is emphysema: permanent destruction of the lung’s gas-exchanging surfaces, which can never fully recover.
How Much Smoking Raises the Risk
Risk scales with how much and how long you smoke, measured in “pack-years” (one pack per day for one year equals one pack-year). A large nationwide cohort study of young adults found a clear dose-response pattern. Compared to nonsmokers, people with fewer than 10 pack-years had a modestly elevated risk (about 27% higher). Those with 10 to 20 pack-years were 55% more likely to develop COPD. And people who accumulated 20 or more pack-years had more than double the risk, with the highest incidence rate of any group.
Not every smoker develops COPD, though. Estimates suggest that about 20 to 30% of long-term smokers eventually do. Individual susceptibility varies based on genetics, other exposures, and factors researchers still don’t fully understand. But there’s no safe threshold of smoking where the risk disappears entirely.
Secondhand Smoke Matters Too
You don’t have to smoke yourself to develop smoking-related COPD. Data from a large U.S. national health survey found that adults exposed to secondhand smoke had roughly 73% higher odds of having COPD compared to those with no exposure. That’s nearly double the risk, and the association held up after adjusting for other factors. Living with a smoker, working in smoke-filled environments, or growing up in a household with smoking parents all contribute to cumulative lung damage over time.
COPD Without Smoking
In low- and middle-income countries, smoking accounts for only 30 to 40% of COPD cases. The biggest non-smoking risk factor globally is household air pollution, particularly from cooking and heating with biomass fuels like wood, animal dung, and crop residue in poorly ventilated spaces. This affects hundreds of millions of people, disproportionately women in developing regions.
Workplace exposures are another well-established cause. Mining, quarrying, concrete work, blasting, and insulation jobs expose workers to inorganic dust that reaches the deepest parts of the lungs. A large cross-sectional study of over 27,000 people, including nearly 14,000 who had never smoked, found that occupational exposure to inorganic dust increased the odds of emphysema by 46% among nonsmokers. Exposure to industrial fumes showed a similarly strong association. Cadmium dust, coal dust, and silica dust have all been linked to emphysema in occupational studies.
Genetics plays a smaller but important role. The best-known genetic risk factor is a condition called alpha-1 antitrypsin deficiency, which affects roughly 1 to 2% of people with emphysema. The body fails to produce enough of a protective protein that normally shields the lungs from enzyme damage. People with this deficiency develop emphysema earlier in life, often with more severe disease than their smoking history alone would explain. Quitting smoking is especially critical for these individuals, as the combination of genetic vulnerability and smoke exposure accelerates lung function decline dramatically.
E-Cigarettes and COPD Risk
Early evidence suggests vaping isn’t a risk-free alternative when it comes to COPD. Analysis of a large federal survey found that e-cigarette users who had never smoked traditional cigarettes were 75% more likely to report having COPD compared to people who had never used either product. Among those who both vaped and smoked, the odds of COPD were roughly six times higher than for people who used neither. Those numbers come with a caveat: the studies show an association, not proof that vaping directly causes COPD. But the pattern is concerning enough that respiratory researchers are paying close attention.
What Happens When You Quit
Quitting smoking is the single most effective way to slow COPD progression. It is, in fact, the only intervention consistently shown to reduce the accelerated rate of lung function decline that defines the disease. Current smokers lose lung capacity faster than nonsmokers every year. After quitting, that rate of decline slows significantly, bringing it closer to what a nonsmoker would experience. The lungs don’t fully heal, and damage already done to the air sacs is permanent. But quitting changes the trajectory. Inflammation decreases, mucus production can improve, and the remaining healthy lung tissue gets a chance to function without constant chemical assault.
This benefit applies at any stage. Even people already diagnosed with moderate or severe COPD experience slower decline after quitting. For those with alpha-1 antitrypsin deficiency, the effect is especially pronounced. The sooner you quit, the more lung function you preserve, but it’s never too late for it to matter.
The Global Picture
COPD is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, about 5% of all deaths globally. It ranks as the eighth leading cause of disability. These numbers reflect a disease driven largely, but not exclusively, by tobacco. In wealthier nations, smoking prevention and cessation remain the most powerful tools for reducing COPD burden. In lower-income countries, reducing household air pollution and occupational dust exposure are equally urgent priorities.